Specialty Pharmacy

Top news of the day from across the health care landscape.

FDA issues safety warning for canagliflozin in the treatment of type 2 diabetes.

Nanoparticle precisely delivers tumor antigens to immune cells while stimulating immunity.

Breast cancer incidence has climbed among Asian Americans, while diagnosis rates among other groups have trended downward.

An improved test for Zika virus could prevent birth defects.

Investing in diagnostic resources, prevention, and treatment programs are vital to ending the HIV epidemic in the United States.

Tracking unstable chromosomes allows scientists to peer into the evolution of NSCLC.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can differentiate themselves from the competition.

Keytruda found to improve the overall response rate in pediatric and adult patients with cHL.

Study found no statistically significant differences when switching from biologic to biosimilar.

Study examines how bacteria in the digestive tract might increase or decrease response to cancer drugs.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.

The World Health Organization recently announced plans to launch a pilot program for prequalifying biosimilars.

Top news of the day from across the health care landscape.

Chronic hepatitis B virus is still a problem in many parts of the world and the United States, despite the availability of a vaccine.

Top news of the week in oncology and cancer drug development.

A robust data reporting infrastructure would greatly benefit specialty pharmacy stakeholders.

Laquinimod fails to outperform placebo in patients with relapsing-remitting MS.

Top news of the day from across the health care landscape.

Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.

Top articles of the week on Specialty Pharmacy Times.

Keytruda improved overall response rate and progression free survival in NSCLC.

HIV has become a chronic disease that requires a different strategy with aging patients.

Findings highlight the need for continuous safety monitoring of novel therapeutics.

The cost of branded, specialty, and generic drugs increased 8.77% in 2016.

Health care use before an initial demyelinating event suggests a measureable prodromal period in multiple sclerosis.

Top news of the day from across the health care landscape.